Health and lifestyle features.

Oxxygen Marketing teams up with NSPCC to Raise Vital Funds

Oxxygen Marketing Partnership, based in Hammersmith, aims to help raise vital funds for the NSPCC by launching a new social media campaign this March.

MTQUA launches world's first international certification in medical tourism for hospitals, clinics, agents

Medical Travel Quality Alliance (MTQUA), promoting better quality and safety for medical tourists since 2009, has launched the first ever international Medical Tourism Certification for health and wellness providers and agencies around the world.

Neogen introduces NeoFilm™ for simple microbial tests

Neogen Corporation (Nasdaq: NEOG) announced today that it has introduced a “clearly better” test system for microbial counts.

Bringing Focus to a World of Light

The International Light Association (ILA) is delighted to announce at their conference in September this year, the inception of an annual International Light Day (ILD) the first of which will be celebrated on 22 September 2013, the autumn equinox.

Betachek launches effort to reduce costs for diabetes patients who have been denied vital blood glucose test strips

According to a new report by Diabetes UK, test strips are being denied or rationed by the NHS to save money. In response to this, a new website has been launched that offers low priced glucose test strips to enable patients to continue their regular testing.

NHS England to support COBIC approach to securing better patient outcomes

The launch event at Coin Street Neighbourhood Centre, London, brought together healthcare leaders from CCGs and CSUs, all keen to adopt outcomes based commissioning for their populations. Bob Ricketts’s opening address called for a much-needed transformation in the commissioning landscape.

Bringing Focus to a World of Light

The International Light Association (ILA) is dedicated to the exploration of the profound effects of light on our health and wellbeing.

National Institute for Health and Care Excellence (NICE) publishes positive Final Appraisal Determination (FAD) for FORXIGA® (dapagliflozin)

Adult patients in England and Wales to gain access to first-in-class Type 2 diabetes treatment.

UNITAID Report Cites Price Reductions of up to 80% for HIV/AIDS, Tuberculosis and Malaria Products

UNITAID’s approach to transform health product markets has delivered price reductions of up to 80% for HIV/AIDS, tuberculosis and malaria medicines and diagnostics for the world’s poor, according to Results Beyond Investment, its 2012 Annual Report just released.

Journée mondiale contre le paludisme – 25 avril 2013 UNITAID souligne la nécessité de mieux cibler la lutte contre le paludisme

Selon UNITAID, après d’importants résultats obtenus dans la lutte contre le paludisme ces dix dernières années, l’action à venir doit être encore mieux ciblée pour que ces progrès soient maintenus.


Subscribe to RSS - Health